0.80 (3.25%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Very Weak
Earnings
Very Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
BioInvent International AB
Telephone
46.46.286.8550
Address
Ideongatan 1, The Gamma Building, Lund, Skane 223 70
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 19.46 - 40.45
Trade Value (12mth)
US$724.00
1 week
14.41%
1 month
16.51%
YTD
-16.58%
1 year
-23.84%
All time high
603.40
EPS 3 yr Growth
632.10%
EBITDA Margin
-146.40%
Operating Cashflow
-kr248m
Free Cash Flow Return
-34.10%
ROIC
-45.80%
Interest Coverage
-824.70
Quick Ratio
5.60
Shares Outstanding (Fully Diluted)
66m
HALO Sector
Healthcare
Next Company Report Date
N/A
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
SEK
Short Sell (% of issue)
0.00
Historical data
Forecast data
| 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | GBP |  | | | | -5.02 | -6.53 | -5.06 | | | | ||
EPS (Fully Diluted) | GBP | | | | | -5.02 | -6.53 | -5.06 | | | | ||
Growth | % | | | | | -626.9 | -29.9 | 22.5 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
